Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 400 of 715 entries
View as:

Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT00310674 Org: User:
Start: 09/30/04 End: - Due: -

Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies

Phase: N/A Priority: Normal
NCT ID: NCT01715779 Org: User:
Start: 08/31/12 End: 06/30/15 Due: 06/30/16

8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00327587 Org: User:
Start: 05/31/06 End: 08/31/07 Due: 08/31/08

Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection

Phase: N/A Priority: Normal
NCT ID: NCT00448227 Org: User:
Start: 10/31/07 End: - Due: -

Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT00646503 Org: User:
Start: 03/31/08 End: 09/30/09 Due: 09/30/10

Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT00310635 Org: User:
Start: 06/30/05 End: - Due: -

Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens

Phase: N/A Priority: Normal
NCT ID: NCT00552214 Org: User:
Start: 08/08/07 End: 07/01/08 Due: 07/01/09

A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa

Phase: N/A Priority: Normal
NCT ID: NCT00134966 Org: User:
Start: 08/31/05 End: 09/30/07 Due: 09/30/08

Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients

Phase: N/A Priority: Normal
NCT ID: NCT00477334 Org: User:
Start: 06/30/07 End: 03/31/09 Due: 03/31/10

Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44

Phase: N/A Priority: Normal
NCT ID: NCT00948766 Org: User:
Start: 07/31/09 End: 06/30/12 Due: 06/30/13

Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010

Phase: N/A Priority: Normal
NCT ID: NCT00945841 Org: User:
Start: 06/30/09 End: 06/30/09 Due: 06/30/10

TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00243763 Org: User:
Start: - End: - Due: -

Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.

Phase: N/A Priority: Normal
NCT ID: NCT00414024 Org: User:
Start: 02/28/07 End: 05/31/07 Due: 05/31/08

Time Course of the Antiproteinuric and Blood Pressure Lowering Effects After Initiation of Renin Inhibition With Aliskiren in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00461136 Org: User:
Start: 08/31/05 End: 11/30/06 Due: 11/30/07

The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.

Phase: N/A Priority: Normal
NCT ID: NCT00154323 Org: User:
Start: 01/31/03 End: 01/31/06 Due: 01/31/07

Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00387517 Org: User:
Start: 10/31/06 End: 08/31/07 Due: 08/31/08

A Study to Assess the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT00380380 Org: User:
Start: 01/31/06 End: 11/30/06 Due: 11/30/07

1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00929110 Org: User:
Start: 06/30/09 End: 04/30/11 Due: 04/30/12

Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise

Phase: N/A Priority: Normal
NCT ID: NCT00819767 Org: User:
Start: 02/28/09 End: 10/31/09 Due: 10/31/10

Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS

Phase: N/A Priority: Normal
NCT ID: NCT00142987 Org: User:
Start: 04/30/04 End: 06/30/05 Due: 06/30/06

Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India

Phase: N/A Priority: Normal
NCT ID: NCT01547715 Org: User:
Start: 03/31/12 End: 04/30/14 Due: 04/30/15

Acute Safety, Tolerability, Feasibility and Pharmacokinetics of Intrath. Administered ATI355 in Patients With Acute SCI

Phase: N/A Priority: Normal
NCT ID: NCT00406016 Org: User:
Start: 05/31/06 End: 09/30/11 Due: 09/30/12

Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00219219 Org: User:
Start: 09/30/03 End: 10/31/06 Due: 10/31/07

A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo

Phase: N/A Priority: Normal
NCT ID: NCT01005901 Org: User:
Start: 10/31/09 End: 12/31/10 Due: 12/31/11

Study to Evaluate the Efficacy, Safety, Tolerability and Immunogenicity of 100µg NIC002 Vaccine in Cigarette Smokers Who Are Motivated to Quit Smoking.

Phase: N/A Priority: Normal
NCT ID: NCT00736047 Org: User:
Start: 08/31/08 End: 10/31/09 Due: 10/31/10